Get an alert when MEDPRO HEALTHCARE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2024-09-30

Confirmation statement due

2026-07-12 (in 2mo)

Last made up 2025-06-28

Watchouts

2 items

Cash

£11M

+88.3% vs 2023

Net assets

£9M

+22.1% vs 2023

Employees

1

0% vs 2023

Profit before tax

£2M

-36.3% vs 2023

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

2-year trend · latest reflected 2024-09-30

Metric Trend 2023-09-302024-09-30
Turnover £34,122,672£25,698,557
Operating profit £3,300,652£2,153,815
Profit before tax £3,381,218£2,153,815
Net profit £2,950,652£1,586,591
Cash £5,606,180£10,556,412
Total assets less current liabilities £7,175,500£8,763,436
Net assets £7,175,500£8,762,091
Equity £7,175,500£8,762,091
Average employees 11
Wages £127,200

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-09-302024-09-30
Operating margin 9.7%8.4%
Net margin 8.6%6.2%
Return on capital employed 46.0%24.6%
Current ratio 1.69x1.69x
Interest cover 76.22x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102 §1A
Reporting scope
Standalone (parent only)
Auditor
Kishens Limited
Audit opinion
Qualified
Going concern
Affirmed

“The company has entered into strategic agreements and partnerships for the developmet of products and marketing authorization to alleviate the impact of these issues. Revenues have taken a upward trend in the current period to 30 September 2024 and are expected improve top and bottom lines in the forseeable future.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

1 active · 1 resigned

Name Role Appointed Born Nationality
RUPRAI, Kalvinder Singh Director 2013-04-22 Jul 1969 British
Show 1 resigned officer
Name Role Appointed Resigned
LYALL, Ravinder Singh Director 2013-04-22 2013-04-24

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Garusa Pharma Solutions Ltd Corporate entity Shares 25–50%, Voting 25–50% 2023-06-27 Ceased 2026-03-27
Mr Kalvinder Ruprai Individual Shares 50–75%, Voting 50–75% 2016-04-06 Active

Filing timeline

Last 20 of 47 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2026-04-11 RESOLUTIONS Resolution
  • 2026-04-11 RESOLUTIONS Resolution
  • 2026-04-11 MA Memorandum articles
Date Type Category Description
2026-05-12 SH06 capital Capital cancellation shares
2026-05-12 SH03 capital Capital return purchase own shares
2026-04-17 AA01 accounts Change account reference date company previous extended PDF
2026-04-11 RESOLUTIONS resolution Resolution
2026-04-11 RESOLUTIONS resolution Resolution
2026-04-11 MA incorporation Memorandum articles
2026-04-01 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2026-04-01 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-11-04 AA accounts Accounts with accounts type full
2025-10-13 AAMD accounts Accounts amended with accounts type full
2025-07-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-06-28 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-06-16 AA accounts Accounts with accounts type full
2023-07-11 AA accounts Accounts with accounts type full
2023-06-28 SH01 capital Capital allotment shares PDF
2023-06-28 CS01 confirmation-statement Confirmation statement with updates PDF
2023-06-28 PSC04 persons-with-significant-control Change to a person with significant control PDF
2023-06-28 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2023-05-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-28 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
11

last 12 months

Capital events
2

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-09-30 vs 2023-09-30

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page